Novo A/S is the holding company in the Novo Group, a family of independent companies owned by the Novo Nordisk Foundation. We are the major shareholder in the Group’s three publicly listed companies, Novo Nordisk A/S, Novozymes A/S and NNIT A/S.
Our primary obligation is to manage the Foundation’s financial assets, ensuring sufficient financial returns to cover its grant obligations to scientific, social and humanitarian purposes and projects throughout Scandinavia and beyond. We do so by investing in life science companies in Europe and North America. Furthermore, we invest in a portfolio of financial assets.